Albuterol would be unlikely to help in which scenario?

• A. Lower airway obstruction
• B. Cardiac-related dyspnea
• C. Chronic cough without bronchospasm
• D. Upper airway problems

Answer: (D)

Albuterol is a bronchodilator that relaxes the smooth muscle in the lower airways, easing bronchospasm and improving airflow when the problem is in the bronchi and bronchioles. Because it acts specifically on those lower-airway smooth muscles, it helps most when the obstruction is due to bronchoconstriction, such as in asthma or other lower airway diseases.

It would be unlikely to help with upper airway problems because the obstruction in that region—the throat, larynx, or trachea above the bronchi—does not involve bronchial smooth muscle. Albuterol won’t reduce swelling, relieve a foreign body obstruction, or address other issues causing upper airway compromise, so its effect there would be minimal.

Cardiac-related dyspnea is typically from the heart's inability to pump effectively or from fluid overload, not from bronchial constriction, so a bronchodilator addresses the wrong mechanism and wouldn’t resolve the underlying cause (and can even cause unwanted tachycardia).

Chronic cough without bronchospasm isn’t driven by bronchial constriction, so there’s little or no bronchodilator benefit either.

Thus, the most unlikely scenario for a beneficial response to albuterol is an upper airway problem, where the obstruction lies above the lower airways and bronchodilators have no target.